H-alpha-Me-L-Phe(4-I)-OH

H-alpha-Me-L-Phe(4-I)-OH is a chiral, alpha-methylated L-phenylalanine derivative bearing an iodinated para-substituted phenyl side chain and a free carboxylic acid. The α-methyl substituent increases steric bulk around the amino acid backbone and can influence conformational preferences during peptide coupling and subsequent transformations. The para-iodo group provides a chemically distinct handle for electrophilic aromatic substitution, cross-coupling, and radiolabel-compatible chemistry, while the unprotected acid functionality supports conversion to activated esters or amide-forming derivatives. As a stereodefined amino acid intermediate, it can be incorporated into peptide-like constructs or used to generate chiral analogs for structure-guided synthesis, chemical biology probes, and downstream derivatization.

1. Peptide Synthesis

H-alpha-Me-L-Phe(4-I)-OH is applied in peptide building workflows where amino acid coupling chemistry benefits from its defined L-configuration and carboxylic acid functionality. The α-methylated backbone can be leveraged to introduce steric constraints that modulate amide bond formation kinetics and the conformational landscape of resulting peptide segments. The para-iodophenyl side chain serves as a late-stage functional handle that can be maintained during protected amino acid assembly or transformed after chain assembly via cross-coupling or electrophilic substitution. The compound can therefore function as a stereochemically controlled peptide building block precursor for peptide analog construction and peptidomimetic libraries.

2. Side-Chain Functionalization

H-alpha-Me-L-Phe(4-I)-OH is used for side-chain derivatization strategies in synthetic organic chemistry and chemical biology reagent preparation. The para-iodo substituent enables halogen-to-functionality conversion routes such as palladium-catalyzed cross-coupling to install aryl, heteroaryl, or substituted motifs, including handles for further conjugation. The α-methyl stereocenter and the phenylalanine-derived aromatic ring provide a rigid, chiral scaffold that can improve interpretability of structure-property relationships across analog series. The resulting iodinated-to-functionalized derivatives support downstream generation of labeled probes, binding-site mimics, and chemically diverse amino acid analogs.

3. Chiral SAR Studies

H-alpha-Me-L-Phe(4-I)-OH is suitable for structure-activity relationship studies where stereochemistry and aromatic substitution pattern are key variables. The L-configuration at the amino acid center combined with the α-methyl group introduces a controlled stereochemical element that can alter local backbone geometry and side-chain orientation in SAR-focused libraries. The para-iodine atom provides a distinctive substituent class that can be systematically varied through cross-coupling to probe electronic and steric effects on molecular recognition. The compound can be employed as a chiral intermediate for preparing analog panels that support medicinal chemistry-style SAR mapping and fragment-to-lead optimization workflows.

4. Radiolabel-Compatible Chemistry

H-alpha-Me-L-Phe(4-I)-OH is applied in radiochemistry-adjacent synthetic planning where an aryl iodide can serve as a platform for isotope-compatible labeling approaches. The para-iodophenyl group offers a chemically defined iodine locus that can be retained for labeling strategies or transformed into alternative aryl substituents while maintaining the amino acid core stereochemistry. The α-methylated L-phenylalanine backbone can help generate labeled analogs with controlled conformational behavior relative to non-methylated counterparts. The compound thus functions as a chiral amino acid intermediate for constructing iodinated probes and radiolabel-ready molecular scaffolds used in analytical and biochemical research contexts.

5. Pharmaceutical Intermediate Preparation

H-alpha-Me-L-Phe(4-I)-OH is utilized in pharmaceutical intermediate preparation where protected amino acid synthesis routes require stereodefined chiral inputs and robust functional-group management. The free carboxylic acid can be converted into activated derivatives for amide coupling steps in the assembly of peptide-like intermediates, while the α-methyl stereocenter supports the generation of constrained analogs used in medicinal chemistry programs. The para-iodo aromatic group can be carried through early synthetic stages and then converted to substituted aryl motifs to diversify chemical matter without changing the amino acid backbone identity. The compound therefore serves as a process-relevant chiral building block for fine chemical synthesis and manufacturing-oriented intermediate generation.

6. Chemical Biology Probes

H-alpha-Me-L-Phe(4-I)-OH is applied in chemical biology for probe and conjugate construction where a chiral amino acid scaffold and a reactive aromatic handle are required. The phenylalanine-derived aromatic ring and α-methyl stereocenter support incorporation into peptide mimics that can engage target binding pockets with defined spatial constraints. The para-iodo group can be used to introduce additional functional groups for affinity tags, clickable moieties, or bioconjugation-ready substituents via cross-coupling chemistry. The resulting labeled or functionalized amino acid derivatives can be used to build molecular probes for pathway mapping, target engagement studies, and mechanistic investigations in biochemical research.

1. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

2. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

3. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die

4. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

5. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis